Lista de obras - Daniel A Weintraub - Dominio Público Uruguay

A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes Measurement

artículo científico publicado en 2017

APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease

artículo científico publicado en 2014

Advances in the treatment of cognitive impairment in Parkinson's disease

artículo científico

Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease

artículo científico publicado en 2011

Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study

artículo científico publicado en 2010

Amyloid-Beta Positron Emission Tomography Imaging of Alzheimer's Pathology in Parkinson's Disease Dementia

artículo científico publicado en 2016

An Alzheimer's Disease-Derived Biomarker Signature Identifies Parkinson's Disease Patients with Dementia

artículo científico publicado en 2016

Antidepressant studies in Parkinson's disease: a review and meta-analysis

artículo científico publicado en 2005

Antipsychotic Use and Physical Morbidity in Parkinson Disease

artículo científico publicado en 2017

Anxiety has specific syndromal profiles in Parkinson disease: a data-driven approach

artículo científico publicado en 2013

Anxiety rating scales in Parkinson's disease: critique and recommendations

scientific article published on October 2008

Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations

artículo científico publicado en 2008

Assessing the executive function deficits of patients with Parkinson's disease: utility of the Tower of London-Drexel.

artículo científico publicado en 2004

Association between cognition and function in patients with Parkinson disease with and without dementia

artículo científico publicado en 2010

Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease

artículo científico publicado en 2016

Association of dopamine agonist use with impulse control disorders in Parkinson disease

artículo científico publicado en 2006

Attitudes regarding the etiology and treatment of depression in Parkinson's disease: a qualitative study

scientific article published on June 2008

Atypical antipsychotic use and mortality risk in Parkinson disease

scientific article published in 2022

CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study

artículo científico publicado en 2016

CSF β-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson Disease

artículo científico publicado en 2015

Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis

artículo científico publicado en 2019

Clinical Follow-up of Parkinson's Disease With Newly Prescribed Quetiapine

artículo científico publicado en 2020

Clinical and Dopamine Transporter Imaging Characteristics of Leucine- Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study

scientific article published on 19 February 2020

Clinical spectrum of impulse control disorders in Parkinson's disease

artículo científico publicado en 2014

Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study

artículo científico publicado en 2016

Clinical-genetic model predicts incident impulse control disorders in Parkinson's disease

artículo científico publicado en 2016

Cognition among individuals along a spectrum of increased risk for Parkinson's disease

artículo científico publicado en 2018

Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings

artículo científico publicado en 2015

Cognitive decline in Parkinson disease

artículo científico publicado en 2017

Cognitive impairment in nondemented Parkinson's disease

artículo científico publicado en 2011

Cognitive profile of LRRK2-related Parkinson's disease

artículo científico publicado en 2015

Course of psychiatric symptoms and global cognition in early Parkinson disease

artículo científico publicado en 2014

Daily affect in Parkinson disease is responsive to life events and motor symptoms

artículo científico publicado en 2006

Decreased ventral striatal activity with impulse control disorders in Parkinson's disease

artículo científico publicado en 2010

Depression rating scales in Parkinson's disease: critique and recommendations

artículo científico publicado en 2007

Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study

artículo científico publicado en 2015

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

artículo científico publicado en 2012

Differences in the Presentation and Progression of Parkinson's Disease by Sex

artículo científico publicado en 2020

Dimensions of executive function in Parkinson's disease

artículo científico publicado en 2005

Dopamine and impulse control disorders in Parkinson's disease

artículo científico publicado en 2008

Drug Insight: impulse control disorders and dopamine therapies in Parkinson's disease

artículo científico publicado en 2007

Effect of age on geriatric depression scale performance in Parkinson's disease

artículo científico publicado en 2007

Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.

artículo científico publicado en 2004

Evidence for impaired encoding and retrieval memory profiles in Parkinson disease.

artículo científico publicado en 2004

Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease

artículo científico publicado en 2020

Factor Analysis and Clustering of the Movement Disorder Society-Non-Motor Rating Scale

scientific article published on 27 March 2020

GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease

artículo científico publicado en 2015

Genetic influences on cognitive decline in Parkinson's disease

artículo científico publicado en 2012

High patient satisfaction with telehealth in Parkinson disease: A randomized controlled study

artículo científico publicado en 2016

Impulse control and related behaviors in Parkinson's disease with dementia

scientific article published on 11 February 2020

Impulse control and related disorders in Mexican Parkinson's disease patients.

artículo científico publicado en 2014

Impulse control and related disorders in Parkinson's disease

artículo científico publicado en 2012

Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients

artículo científico publicado en 2010

Impulse control disorders in Parkinson disease: a multicenter case--control study.

artículo científico publicado en 2011

Impulse control disorders in Parkinson's disease

artículo científico publicado en 2006

Impulse control disorders in Parkinson's disease: prevalence and possible risk factors

artículo científico publicado en 2009

Impulsive and compulsive behaviors in Parkinson's disease.

artículo científico publicado en 2009

Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease

artículo científico publicado en 2015

Intervening in the neuropsychiatric features of Parkinson's disease

artículo científico publicado en 2007

Is RBD a risk factor for impulse control disorder in Parkinson's disease?

artículo científico publicado en 2020

Is depression in Parkinson's disease (PD) a specific entity?

artículo científico publicado en 2011

Is the Parkinson anxiety scale comparable across raters?

scholarly article by Maria João Forjaz et al published 27 December 2014 in Movement Disorders

Long-term follow-up of impulse control disorders in Parkinson's disease

artículo científico publicado en 2008

Longitudinal study of normal cognition in Parkinson disease

artículo científico publicado en 2015

Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype

artículo científico publicado en 2014

MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

artículo científico publicado en 2011

Management of psychiatric disorders in Parkinson's disease : Neurotherapeutics - Movement Disorders Therapeutics

artículo científico publicado en 2020

Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores

artículo científico publicado en 2008

Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score

scientific article published on 10 December 2008

Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease

artículo científico publicado en 2017

Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study

artículo científico publicado en 2014

Neurodegeneration across stages of cognitive decline in Parkinson disease

artículo científico publicado en 2011

Neuropsychiatric symptoms and caregiver's burden in Parkinson's disease

artículo científico publicado en 2015

Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease

scientific article published on 13 April 2020

Neuropsychiatric symptoms in Parkinson disease and dementia with Lewy bodies: what geriatric psychiatry can learn

artículo científico publicado en 2013

Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsy

artículo científico publicado en 2012

Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease

artículo científico publicado en 2011

Optimizing olfactory testing for the diagnosis of Parkinson's disease: item analysis of the university of Pennsylvania smell identification test

artículo científico publicado en 2018

Parkinson's disease--Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment.

scientific article published on March 2008

Parkinson's disease--Part 2: Treatment of motor symptoms.

artículo científico publicado en 2008

Parkinson's disease--Part 3: Neuropsychiatric symptoms

artículo científico publicado en 2008

Parkinson's disease: the quintessential neuropsychiatric disorder

artículo científico publicado en 2011

Patterns and trends in antipsychotic prescribing for Parkinson disease psychosis

artículo científico publicado en 2011

Patterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease

artículo científico publicado en 2019

Patterns of cortical thickness associated with impulse control disorders in Parkinson's disease

artículo científico publicado en 2015

People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance

artículo científico publicado en 2014

Phenylthiocarbamide (PTC) perception in Parkinson disease.

artículo científico publicado en 2007

Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications

scholarly article by Alberto J. Espay et al published 2 November 2018 in Movement Disorders

Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease

artículo científico publicado en 2010

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2010

Predictors of anxiety in early-stage Parkinson's disease - Results from the first two years of a prospective cohort study

artículo científico

Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies

artículo científico publicado en 2007

Psychiatric complications in Parkinson disease

artículo científico publicado en 2005

Psychosis in Parkinson's disease without dementia: common and comorbid with other non-motor symptoms

artículo científico publicado en 2012

Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale

artículo científico publicado en 2011

Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia

artículo científico publicado en 2017

Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative

artículo científico publicado en 2017

Rivastigmine for mild cognitive impairment in Parkinson disease: a placebo-controlled study

artículo científico publicado en 2015

Rivastigmine in Alzheimer's disease and Parkinson's disease dementia: an ADAS-cog factor analysis

artículo científico publicado en 2011

Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study

artículo científico publicado en 2013

Subjective Cognitive Complaint in Parkinson's Disease Patients with Normal Cognition: Canary in the Coal Mine?

scientific article published on 10 June 2020

Suicidal and death ideation in Parkinson's disease

artículo científico publicado en 2008

Suicide ideation and behaviours after STN and GPi DBS surgery for Parkinson's disease: results from a randomised, controlled trial

artículo científico publicado en 2013

TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementia

scholarly article by Thomas F. Tropea et al published 14 May 2019 in Annals of Neurology

Tau pathology associates with in vivo cortical thinning in Lewy body disorders

scientific article published on 27 October 2020

Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease

artículo científico publicado en 2006

The Danger of Not Treating Parkinson Disease Psychosis-Reply

artículo científico publicado en 2016

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

artículo científico publicado en 2011

The Parkinson Anxiety Scale (PAS): development and validation of a new anxiety scale

artículo científico publicado en 2014

The Penn Parkinson's Daily Activities Questionnaire-15: Psychometric properties of a brief assessment of cognitive instrumental activities of daily living in Parkinson's disease

artículo científico publicado en 2016

The course of depressive symptoms in early Parkinson's disease

artículo científico publicado en 2009

The depressed brain in Parkinson's disease: Implications for an inflammatory biomarker

artículo científico publicado en 2017

The psychosis spectrum in Parkinson disease

artículo científico publicado en 2017

Treatment of early Parkinson's disease. Part 1.

artículo científico publicado en 2009

Treatment of early Parkinson's disease. Part 2.

artículo científico publicado en 2009

Use of latent variable modeling to delineate psychiatric and cognitive profiles in Parkinson disease

artículo científico publicado en 2009

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression

scientific article published on 15 August 2020

Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease

artículo científico publicado en 2009

Lista de obras de Daniel A Weintraub

A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes Measurement

APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease

Advances in the treatment of cognitive impairment in Parkinson's disease

Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease

Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study

Amyloid-Beta Positron Emission Tomography Imaging of Alzheimer's Pathology in Parkinson's Disease Dementia

An Alzheimer's Disease-Derived Biomarker Signature Identifies Parkinson's Disease Patients with Dementia

Antidepressant studies in Parkinson's disease: a review and meta-analysis

Antipsychotic Use and Physical Morbidity in Parkinson Disease

Anxiety has specific syndromal profiles in Parkinson disease: a data-driven approach

Anxiety rating scales in Parkinson's disease: critique and recommendations

Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations

Assessing the executive function deficits of patients with Parkinson's disease: utility of the Tower of London-Drexel.

Association between cognition and function in patients with Parkinson disease with and without dementia

Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease

Association of dopamine agonist use with impulse control disorders in Parkinson disease

Attitudes regarding the etiology and treatment of depression in Parkinson's disease: a qualitative study

Atypical antipsychotic use and mortality risk in Parkinson disease

CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study

CSF β-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson Disease

Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis

Clinical Follow-up of Parkinson's Disease With Newly Prescribed Quetiapine

Clinical and Dopamine Transporter Imaging Characteristics of Leucine- Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study

Clinical spectrum of impulse control disorders in Parkinson's disease

Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study

Clinical-genetic model predicts incident impulse control disorders in Parkinson's disease

Cognition among individuals along a spectrum of increased risk for Parkinson's disease

Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings

Cognitive decline in Parkinson disease

Cognitive impairment in nondemented Parkinson's disease

Cognitive profile of LRRK2-related Parkinson's disease

Course of psychiatric symptoms and global cognition in early Parkinson disease

Daily affect in Parkinson disease is responsive to life events and motor symptoms

Decreased ventral striatal activity with impulse control disorders in Parkinson's disease

Depression rating scales in Parkinson's disease: critique and recommendations

Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

Differences in the Presentation and Progression of Parkinson's Disease by Sex

Dimensions of executive function in Parkinson's disease

Dopamine and impulse control disorders in Parkinson's disease

Drug Insight: impulse control disorders and dopamine therapies in Parkinson's disease

Effect of age on geriatric depression scale performance in Parkinson's disease

Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.

Evidence for impaired encoding and retrieval memory profiles in Parkinson disease.

Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease

Factor Analysis and Clustering of the Movement Disorder Society-Non-Motor Rating Scale

GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease

Genetic influences on cognitive decline in Parkinson's disease

High patient satisfaction with telehealth in Parkinson disease: A randomized controlled study

Impulse control and related behaviors in Parkinson's disease with dementia

Impulse control and related disorders in Mexican Parkinson's disease patients.

Impulse control and related disorders in Parkinson's disease

Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients

Impulse control disorders in Parkinson disease: a multicenter case--control study.

Impulse control disorders in Parkinson's disease

Impulse control disorders in Parkinson's disease: prevalence and possible risk factors

Impulsive and compulsive behaviors in Parkinson's disease.

Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease

Intervening in the neuropsychiatric features of Parkinson's disease

Is RBD a risk factor for impulse control disorder in Parkinson's disease?

Is depression in Parkinson's disease (PD) a specific entity?

Is the Parkinson anxiety scale comparable across raters?

Long-term follow-up of impulse control disorders in Parkinson's disease

Longitudinal study of normal cognition in Parkinson disease

Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype

MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

Management of psychiatric disorders in Parkinson's disease : Neurotherapeutics - Movement Disorders Therapeutics

Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores

Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score

Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease

Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study

Neurodegeneration across stages of cognitive decline in Parkinson disease

Neuropsychiatric symptoms and caregiver's burden in Parkinson's disease

Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease

Neuropsychiatric symptoms in Parkinson disease and dementia with Lewy bodies: what geriatric psychiatry can learn

Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsy

Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease

Optimizing olfactory testing for the diagnosis of Parkinson's disease: item analysis of the university of Pennsylvania smell identification test

Parkinson's disease--Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment.